The European Union has called on its top corporations and CEOs to swiftly detail their U.S. investment plans, as Brussels seeks to gain leverage in ongoing trade negotiations with Washington, according to two sources familiar with the matter.

Members of BusinessEurope, the bloc’s primary business alliance comprising 42 national industry federations, received a survey from the European Commission on Monday requesting information about upcoming investments in the United States. One source said the Commission urged companies to respond as soon as possible.

A similar request was sent to the European Roundtable for Industry (ERT)—a group of 59 CEOs from leading firms including asml, BASF, sap, BMW, and Mercedes-Benz. The message reportedly came directly from European Commission President Ursula von der Leyen, asking for investment projections over the next five years.

BusinessEurope’s membership spans major sectors such as automotive, aerospace, and pharmaceuticals, including many of Germany’s largest employers.

This information-gathering comes as the Commission intensifies efforts to reach a trade deal with the U.S. that could eliminate or at least prevent the increase of tariffs on EU goods. The EU has proposed a deal including zero tariffs on industrial goods, alongside commitments to increase imports of U.S. soybeans, arms, and liquefied natural gas.

However, U.S. President Donald Trump has not been satisfied with the progress. After threatening to raise tariffs on EU goods to 50% starting June 1, he announced a delay until July 9 following a phone call with von der Leyen.

Trump meets President of EU von der Leyen in 2020

According to EU diplomats, the leaders did not reach substantive agreements but did agree to accelerate discussions and strengthen engagement.

EU Trade Commissioner Maroš Šefčovič confirmed on Monday that he held “productive” calls with U.S. Commerce Secretary Mike Lutnick and Trade Representative Katherine Greer. “The European Commission remains committed to advancing negotiations with the U.S. constructively and will continue close engagement,” he posted on social media platform X.

So far, the largest U.S.-bound investment pledges have come from the pharmaceutical sector. Swiss giants Roche and Novartis have committed $50 billion and $23 billion, respectively, while France’s Sanofi plans to invest at least $20 billion by 2030.

At least seven other European firms have also announced intentions to boost U.S. investments, though most have yet to release detailed figures.